免疫抑制薬の世界市場レポート（2024年）

レポートナンバー　0000037754

免疫抑制薬の世界市場レポート（2024年）

The Business Research Company

Immunosuppressants Global Market Report 2024

発刊日 2024/02/23

言語英語

体裁PDF/250ページ

ライセンス/価格250ページ

0000037754

Single	5,000USD
Site	7,500USD
Enterprise	10,000USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

本レポートは、免疫抑制薬の世界市場に関して、戦略家、マーケティング担当者、上級管理職が市場を評価するために必要な重要情報を提供します。

本レポートは、力強い成長を遂げている免疫抑制薬市場に焦点を当て、今後10年およびそれ以降の市場を形成するトレンドについてのガイドを提供します。

調査範囲

調査市場
➣ 薬剤クラス別
　　◇ コルチコステロイド
　　◇ モノクローナル抗体（mAb）
　　◇ カルシニューリン阻害薬
　　◇ mTOR阻害薬
　　◇ 抗増殖薬
　　◇ その他
➣ 適応症別
　　◇ 臓器移植
　　◇ 自己免疫疾患
　　◇ 非自己免疫性炎症性疾患
➣ 流通チャネル別
　　◇ 病院薬局
　　◇ 小売薬局
　　◇ オンライン薬局
調査企業
➣ Pfizer Inc.
➣ Johnson & Johnson Services Inc.
➣ BASF SE
➣ F Hoffmann La Roche Ltd.
➣ AbbVie Inc.
調査国
オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、イギリス、アメリカ、カナダ、イタリア、スペイン
調査地域
➣ アジア太平洋地域
➣ 西ヨーロッパ
➣ 東ヨーロッパ
➣ 北アメリカ
➣ 南アメリカ
➣ 中東
➣ アフリカ
調査期間
➣ 5年間の実績データおよび10年間の予測
データ
➣ 市場規模と成長率の関連市場に対する比率
➣ GDP比率
➣ 一人当たりの支出
データセグメント
➣ 国別・地域別の実績および予測データ
➣ 競合企業の市場シェア
➣ 市場セグメント
情報源および参照
➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。
提供形態
➣ PDF、Word、Excelデータダッシュボード

レポート詳細

5. Global Immunosuppressants Market Size and Growth
5.1. Global Immunosuppressants Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Immunosuppressants Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Immunosuppressants Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Immunosuppressants Market Segmentation
6.1. Global Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Corticosteroids
Monoclonal Antibodies (mAbs)
Calcineurin Inhibitors
mTOR Inhibitors
Anti-Proliferative Agents
Other Drug Classes
6.2. Global Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Organ Transplantation
Autoimmune Disorders
Non-Autoimmune Inflammatory Diseases
6.3. Global Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

7. Immunosuppressants Market Regional And Country Analysis
7.1. Global Immunosuppressants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Immunosuppressants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Immunosuppressants Market
8.1. Asia-Pacific Immunosuppressants Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Immunosuppressants Market
9.1. China Immunosuppressants Market Overview
9.2. China Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Immunosuppressants Market
10.1. India Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Immunosuppressants Market
11.1. Japan Immunosuppressants Market Overview
11.2. Japan Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Immunosuppressants Market
12.1. Australia Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Immunosuppressants Market
13.1. Indonesia Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Immunosuppressants Market
14.1. South Korea Immunosuppressants Market Overview
14.2. South Korea Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Immunosuppressants Market
15.1. Western Europe Immunosuppressants Market Overview
15.2. Western Europe Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Immunosuppressants Market
16.1. UK Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Immunosuppressants Market
17.1. Germany Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Immunosuppressants Market
18.1. France Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Immunosuppressants Market
19.1. Italy Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Immunosuppressants Market
20.1. Spain Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Immunosuppressants Market
21.1. Eastern Europe Immunosuppressants Market Overview
21.2. Eastern Europe Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Immunosuppressants Market
22.1. Russia Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Immunosuppressants Market
23.1. North America Immunosuppressants Market Overview
23.2. North America Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Immunosuppressants Market
24.1. USA Immunosuppressants Market Overview
24.2. USA Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Immunosuppressants Market
25.1. Canada Immunosuppressants Market Overview
25.2. Canada Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Immunosuppressants Market
26.1. South America Immunosuppressants Market Overview
26.2. South America Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Immunosuppressants Market
27.1. Brazil Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Immunosuppressants Market
28.1. Middle East Immunosuppressants Market Overview
28.2. Middle East Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Immunosuppressants Market
29.1. Africa Immunosuppressants Market Overview
29.2. Africa Immunosuppressants Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Immunosuppressants Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Immunosuppressants Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Immunosuppressants Market Competitive Landscape And Company Profiles
30.1. Immunosuppressants Market Competitive Landscape
30.2. Immunosuppressants Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson & Johnson Services Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. BASF SE
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. F Hoffmann La Roche Ltd.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. AbbVie Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance

31. Immunosuppressants Market Other Major And Innovative Companies
31.1. Allergan plc
31.2. Novartis AG
31.3. Sanofi SA
31.4. Bristol-Myers Squibb Co.
31.5. GlaxoSmithKline plc
31.6. Covestro AG
31.7. Mylan Laboratories Inc.
31.8. Teva Pharmaceuticals USA Inc.
31.9. Astellas Pharma Inc.
31.10. Sandoz Inc.
31.11. Aurobindo Pharma Limited
31.12. Hikma Pharmaceuticals plc
31.13. Intas Pharmaceuticals Ltd.
31.14. Zydus Lifesciences Limited
31.15. Glenmark Pharmaceuticals Ltd.

32. Global Immunosuppressants Market Competitive Benchmarking

33. Global Immunosuppressants Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Immunosuppressants Market

35. Immunosuppressants Market Future Outlook and Potential Analysis
35.1 Immunosuppressants Market In 2028 - Countries Offering Most New Opportunities
35.2 Immunosuppressants Market In 2028 - Segments Offering Most New Opportunities
35.3 Immunosuppressants Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies

36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000037754

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。